# A MIF-p38-GSDMD inflammatory loop in keratinocytes underlies UVB-induced cutaneous lupus

**Authors:** Chipeng Guo, Siweier Luo, Jigang Luo, Siyao Lu, Xiaomei You, Junlin Cao, Yufei Du, Haoran Lv, Hanzhi Liang, Le Wang, Liangchun Wang, Tao Liu, Yiming Zhou

PMC · DOI: 10.1038/s41419-026-08443-4 · Cell Death & Disease · 2026-02-02

## TL;DR

UVB light triggers cutaneous lupus by activating a feedback loop involving MIF, p38, and GSDMD in skin cells, leading to inflammation.

## Contribution

The study identifies a novel MIF-p38-GSDMD inflammatory loop in keratinocytes that drives UVB-induced cutaneous lupus.

## Key findings

- UVB irradiation induces MIF release from keratinocytes, promoting inflammation and matrix remodeling.
- MIF release occurs via GSDMD pores during pyroptosis, amplifying p38-C/EBPβ signaling in a self-sustaining loop.
- Disrupting the MIF-p38-GSDMD loop reduces epidermal hyperplasia and cytokine imbalance in lupus-prone mice.

## Abstract

Ultraviolet B (UVB) is a well-recognized trigger of cutaneous lupus erythematosus (CLE), yet its molecular basis remains largely undefined. Here, using single-cell transcriptomics and a lupus-prone mouse model, we identify keratinocyte-derived macrophage migration inhibitory factor (MIF) as a key amplifier of cutaneous inflammation through a self-sustaining feedback loop. Single-cell RNA sequencing reveals elevated MIF expression specifically within pathogenic, interferon-high keratinocyte subclusters associated with CLE, which is further validated across major CLE subtypes in clinical skin samples. In vitro, UVB irradiation dose-dependently induces the release of MIF from keratinocytes, which in turn promotes inflammatory signaling and matrix remodeling in both keratinocytes and fibroblasts. Mechanistically, we demonstrate that UVB irradiation activates the ribotoxic stress response (RSR), leading to the p38-C/EBPβ-mediated transcriptional upregulation of NLRP3 and GSDMD cleavage in keratinocytes. The ensuing GSDMD-dependent pyroptosis facilitates the release of MIF, primarily through GSDMD pores rather than vesicular secretion, which in turn amplifies the p38-C/EBPβ signaling pathway. Therapeutic disruption of this loop either by gene silencing via AAVs or pharmacological inhibition via microneedles, markedly attenuates epidermal hyperplasia and cytokine imbalance in lupus-prone mice. These findings uncover a previously unrecognized MIF-p38-GSDMD inflammatory loop contributes to the UVB-induced cutaneous lupus, offering both mechanistic insights and translational opportunities for CLE.

## Linked entities

- **Genes:** MIF (macrophage migration inhibitory factor) [NCBI Gene 4282], CRK (CRK proto-oncogene, adaptor protein) [NCBI Gene 1398], GSDMD (gasdermin D) [NCBI Gene 79792], NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548], CEBPB (CCAAT enhancer binding protein beta) [NCBI Gene 1051]
- **Diseases:** cutaneous lupus erythematosus (MONDO:0005282), CLE (MONDO:0007536)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Mx1 (MX dynamin-like GTPase 1) [NCBI Gene 17857] {aka Mx, Mx-1}, IFI27 (interferon alpha inducible protein 27) [NCBI Gene 3429] {aka FAM14D, ISG12, ISG12A, P27}, Cd74 (CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated)) [NCBI Gene 16149] {aka CLIP, DHLAG, HLADG, Ia-GAMMA, Ii}, MIF (macrophage migration inhibitory factor) [NCBI Gene 4282] {aka GIF, GLIF, MMIF}, Cebpb (CCAAT/enhancer binding protein beta) [NCBI Gene 12608] {aka C/EBPbeta, CRP2, IL-6DBP, LAP, LIP, NF-IL6}, OASL (2'-5'-oligoadenylate synthetase like) [NCBI Gene 8638] {aka OASL1, OASLd, TRIP-14, TRIP14, p59 OASL, p59-OASL}, OAS2 (2'-5'-oligoadenylate synthetase 2) [NCBI Gene 4939] {aka AIAISD2}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, ISG15 (ISG15 ubiquitin like modifier) [NCBI Gene 9636] {aka G1P2, IFI15, IMD38, IP17, UCRP, hUCRP}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, ACTB (actin beta) [NCBI Gene 60] {aka BKRNS, BNS, BRWS1, CSMH, DDS1, PS1TP5BP1}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, Mmp2 (matrix metallopeptidase 2) [NCBI Gene 17390] {aka Clg4a, GelA, MMP-2}, IFITM1 (interferon induced transmembrane protein 1) [NCBI Gene 8519] {aka 9-27, CD225, DSPA2a, IFI17, LEU13}, S100A8 (S100 calcium binding protein A8) [NCBI Gene 6279] {aka 60B8AG, CAGA, CFAG, CGLA, CP-10, L1Ag}, Calcr (calcitonin receptor) [NCBI Gene 12311] {aka Clr, Ct-r}, OAS1 (2'-5'-oligoadenylate synthetase 1) [NCBI Gene 4938] {aka E18/E16, IFI-4, IMD100, OIAS, OIASI}, Mif (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) [NCBI Gene 17319] {aka DER6, GIF, Glif}, Mapk14 (mitogen-activated protein kinase 14) [NCBI Gene 26416] {aka CSBP2, Crk1, Csbp1, Mxi2, PRKM14, PRKM15}, STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772] {aka CANDF7, IMD31A, IMD31B, IMD31C, ISGF-3, STAT91}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, Krt14 (keratin 14) [NCBI Gene 16664] {aka CK-14, K14, Krt-1.14, Krt1-14}, MX1 (MX dynamin like GTPase 1) [NCBI Gene 4599] {aka IFI-78K, IFI78, MX, MxA, lncMX1-215}, KRT14 (keratin 14) [NCBI Gene 3861] {aka CK14, EBS1, EBS1A, EBS1B, EBS1C, EBS1D}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, S100A9 (S100 calcium binding protein A9) [NCBI Gene 6280] {aka 60B8AG, CAGB, CFAG, CGLB, L1AG, LIAG}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, Nlrp1a (NLR family, pyrin domain containing 1A) [NCBI Gene 195046] {aka CARD7, DEFCAP, Gm14, Gm15, NAC, Nalp1}, IFNK (interferon kappa) [NCBI Gene 56832] {aka IFNT1, INFE1}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, CEBPB (CCAAT enhancer binding protein beta) [NCBI Gene 1051] {aka C/EBP-beta, IL6DBP, NF-IL6, TCF5}, OAS3 (2'-5'-oligoadenylate synthetase 3) [NCBI Gene 4940] {aka p100, p100OAS}, Vim (vimentin) [NCBI Gene 22352], CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, VIM (vimentin) [NCBI Gene 7431], RIGI (RNA sensor RIG-I) [NCBI Gene 23586] {aka DDX58, RIG-I, RIG1, RLR-1, SGMRT2}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, GSDMD (gasdermin D) [NCBI Gene 79792] {aka DF5L, DFNA5L, FKSG10, GSDMDC1}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, CD74 (CD74 molecule) [NCBI Gene 972] {aka CLIP, DHLAG, HLADG, II, Ia-GAMMA, p33}, IRF7 (interferon regulatory factor 7) [NCBI Gene 3665] {aka IMD39, IRF-7, IRF-7H, IRF7A, IRF7B, IRF7C}, Gsdmd (gasdermin D) [NCBI Gene 69146] {aka 1810036L03Rik, DF5L, Dfna5l, GsdmD-1, Gsdmdc1, M2-4}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, IFI44L (interferon induced protein 44 like) [NCBI Gene 10964] {aka C1orf29, GS3686, TLDC5B}, COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277] {aka CAFYD, EDSARTH1, EDSC, OI1, OI2, OI3}, IFI44 (interferon induced protein 44) [NCBI Gene 10561] {aka MTAP44, TLDC5, p44}
- **Diseases:** epidermal hyperplasia (MESH:D006965), Lichen sclerosus et atrophicus (MESH:D018459), ACLE (MESH:D008178), irritation (MESH:D001523), Lupus Les (MESH:C535314), Dermatitis (MESH:D003872), autoimmune disease (MESH:D001327), erythema (MESH:D004890), inflammatory skin (MESH:D012878), infection (MESH:D007239), Lupus NonLes (MESH:D008180), toxicity (MESH:D064420), CCLE (MESH:D008179), fibrosis (MESH:D005355), malignancy (MESH:D009369), edema (MESH:D004487), pigmented nevi (MESH:D009508), multi-organ damage (MESH:D000092124), vitiligo (MESH:D014820), DM (MESH:D003882), chronic inflammation (MESH:D007249), Skin lesion (MESH:D012871)
- **Chemicals:** LiCl (MESH:D018021), DAPI (MESH:C007293), bicinchoninic acid (MESH:C047117), brefeldin A (MESH:D020126), formaldehyde (MESH:D005557), SDS (MESH:D012967), Alexa Fluor  488 (MESH:C000711379), PVP (MESH:D011205), glycine (MESH:D005998), 3,3'-diaminobenzidine (MESH:D015100), xylene (MESH:D014992), DMEM (-), H&amp;E (MESH:D006371), glycerol (MESH:D005990), EDTA (MESH:D004492), imiquimod (MESH:D000077271), ethanol (MESH:D000431), streptomycin (MESH:D013307), SB203580 (MESH:C093642), anifrolumab (MESH:C582345), DSF (MESH:D004221), DMSO (MESH:D004121), rituximab (MESH:D000069283), PDMS (MESH:C013830), ANS (MESH:D000841), penicillin (MESH:D010406), NaCl (MESH:D012965), methylene blue (MESH:D008751), Alexa Fluor  555 (MESH:C000608607), CP-456773 (MESH:C000597426), GW4869 (MESH:C468773), belimumab (MESH:C511911), PBS (MESH:D007854), Lipofectamine 2000 (MESH:C086724), MP (MESH:C063925), CO2 (MESH:D002245), Paraffin (MESH:D010232)
- **Species:** Cytomegalovirus (genus) [taxon 10358], Mycoplasma (genus) [taxon 2093], Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** P2083S, -173 G>C, C) with 1
- **Cell lines:** MRL/lpr — Mus musculus (Mouse), Stromal cell line (CVCL_B6HA), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), HaCaT — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0038), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12876878/full.md

## Figures

21 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12876878/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12876878/full.md

---
Source: https://tomesphere.com/paper/PMC12876878